Dysregulation of TDP-43 in ALS and FTLD is an active area of investigation, including the development of biomarkers and therapeutic strategies, such as ASOs, to restore appropriate splicing of TDP-43 targets83–85. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.